| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/22/2001 | WO2001012818A1 Neutral cerebral-sphingomyelinase |
| 02/22/2001 | WO2001012816A2 Porcine endovirus gag and env and diagnostic uses thereof |
| 02/22/2001 | WO2001012813A1 Gene encoding merozoite protein of babesia caballi, recombinant protein obtained therefrom and utilization thereof |
| 02/22/2001 | WO2001012812A2 Baff receptor (bcma), an immunoregulatory agent |
| 02/22/2001 | WO2001012811A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/22/2001 | WO2001012806A2 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 02/22/2001 | WO2001012805A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 02/22/2001 | WO2001012790A2 Isomerase proteins |
| 02/22/2001 | WO2001012786A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012781A1 13 human colon and colon cancer associated proteins |
| 02/22/2001 | WO2001012777A2 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 02/22/2001 | WO2001012776A2 18 human secreted proteins |
| 02/22/2001 | WO2001012775A2 25 human secreted proteins |
| 02/22/2001 | WO2001012674A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 02/22/2001 | WO2001012673A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 02/22/2001 | WO2001012672A2 Cytokine receptor common gamma chain like |
| 02/22/2001 | WO2001012671A1 Human tumor necrosis factor receptor tr16 |
| 02/22/2001 | WO2001012670A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012665A2 Helical cytokine zalpha48 |
| 02/22/2001 | WO2001012664A2 Notch receptor ligands and uses thereof |
| 02/22/2001 | WO2001012663A2 Hematopoietic regulatory factors and methods of use thereof |
| 02/22/2001 | WO2001012662A2 Membrane associated proteins |
| 02/22/2001 | WO2001012648A1 Novel transcription factor, bp1 |
| 02/22/2001 | WO2001012646A1 Sialoadhesin factor-1 agonist and antagonist antibodies |
| 02/22/2001 | WO2001012598A2 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 02/22/2001 | WO2001012224A1 Use of cd28 specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections |
| 02/22/2001 | WO2001012219A1 Pneumococcal vaccines |
| 02/22/2001 | WO2001012217A1 Therapeutic antibody against muc-1 antigen and methods for their use |
| 02/22/2001 | WO2001012212A1 Inhibitors of the lectin complement pathway (lcp) and their use |
| 02/22/2001 | WO2001012172A1 Treatment of metastatic disease |
| 02/22/2001 | WO2000078941A3 Methods and products for manipulating uncoupling protein expression |
| 02/22/2001 | WO2000077179A3 Human poly(adp-ribose) polymerase 2 materials and methods |
| 02/22/2001 | WO2000073427A3 Acetylcholinesterase-derived peptides and uses thereof |
| 02/22/2001 | WO2000064936A3 PEPTIDE HOMODIMERS AND PEPTIDE HETERODIMERS, DERIVED FROM INTERFERON α2 |
| 02/22/2001 | WO2000061765A3 Lipoxygenase proteins and polynucleotides encoding the same |
| 02/22/2001 | WO2000055633A3 Methods of screening for colorectal cancer modulators |
| 02/22/2001 | WO2000040614A3 Characterization of the soc/crac calcium channel protein family |
| 02/22/2001 | WO2000039297A3 Il-1 related polypeptides |
| 02/22/2001 | WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 02/22/2001 | WO1999058680A3 Method for diagnosis and treatment of haemophilia a patients with an inhibitor |
| 02/22/2001 | DE19939653A1 Verwendung CD28 spezifischer monoklonaler Antikörper zur Herstellung einer pharmazeutischen Zusammensetzung Using CD28 specific monoclonal antibodies for the preparation of a pharmaceutical composition |
| 02/22/2001 | DE19939578A1 New nucleic acid encoding hemocyanin, useful for gene therapy of tumors and for recombinant production of fusion proteins for vaccination |
| 02/22/2001 | CA2464845A1 Hematopoietic regulatory factors and methods of use thereof |
| 02/22/2001 | CA2385487A1 13 human colon and colon cancer associated proteins |
| 02/22/2001 | CA2385475A1 18 human secreted proteins |
| 02/22/2001 | CA2385431A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | CA2383922A1 Cytokine receptor common gamma chain like |
| 02/22/2001 | CA2383691A1 Human tumor necrosis factor receptor tr16 |
| 02/22/2001 | CA2383154A1 Baff receptor (bcma), an immunoregulatory agent |
| 02/22/2001 | CA2382655A1 Antibodies as a cancer diagnostic |
| 02/22/2001 | CA2382251A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 02/22/2001 | CA2382205A1 Detection of isomerised epitopes in autoimmune diseases |
| 02/22/2001 | CA2382148A1 25 human secreted proteins |
| 02/22/2001 | CA2382095A1 Methods of inhibiting binding of .beta.-sheet fibril to rage and consequences thereof |
| 02/22/2001 | CA2382048A1 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 02/22/2001 | CA2382019A1 Isomerase proteins |
| 02/22/2001 | CA2382018A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | CA2382015A1 Membrane associated proteins |
| 02/22/2001 | CA2381979A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 02/22/2001 | CA2381863A1 Novel transcription factor, bp1 |
| 02/22/2001 | CA2381794A1 Helical cytokine zalpha48 |
| 02/22/2001 | CA2381712A1 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 02/22/2001 | CA2381706A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 02/22/2001 | CA2380979A1 Inhibitors of the lectin complement pathway (lcp) and their use |
| 02/22/2001 | CA2380936A1 Therapeutic antibody against muc-1 antigen and methods for their use |
| 02/22/2001 | CA2380888A1 Treatment of metastatic disease |
| 02/22/2001 | CA2377662A1 Novel protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 02/21/2001 | EP1077069A1 Preventives/remedies for hepatic cirrhosis |
| 02/21/2001 | EP1076711A2 Human apoptosis associated proteins |
| 02/21/2001 | EP1076710A2 Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 02/21/2001 | EP1076703A2 Il-17 homologous polypeptides and therapeutic uses thereof |
| 02/21/2001 | EP1076702A1 Human protease associated proteins |
| 02/21/2001 | EP1076701A1 Antibodies to cd23, derivatives thereof, and their therapeutic uses |
| 02/21/2001 | EP1076700A2 Human nucleic acid sequences obtained from pancreas tumor tissue |
| 02/21/2001 | EP1076697A2 Semaphorin polypeptides |
| 02/21/2001 | EP1076696A2 Human receptor molecules |
| 02/21/2001 | EP1076689A1 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same |
| 02/21/2001 | EP1076665A1 Oral administration of immunoglobulins for treating autoimmune hearing loss |
| 02/21/2001 | EP0784683B1 Tie-2 ligands, methods of making and uses thereof |
| 02/21/2001 | EP0725825B1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains |
| 02/21/2001 | EP0526452B1 Hybrid immunoglobulins |
| 02/21/2001 | CN1284966A Novel G protein-coupled receptor |
| 02/21/2001 | CN1284965A Novel surface protein of i (neisseria meningitidis) |
| 02/20/2001 | US6191270 Nucleotide sequences coding plasmodium protein; for prevention and immunization against plasmodium infection |
| 02/20/2001 | US6191261 Immunoglobulin that preferential binds a growth factor; for the diagnosis and treatment of cell proliferative defects; antiproliferative agents |
| 02/20/2001 | US6191258 Polypeptide which associates with symetric nucleotide sequences; for the artificial regulation of gene expression in plants |
| 02/20/2001 | US6191255 Isolated matrix metalloproteinase of given amino acid sequence having the activation capability of pro-matrix metalloproteinase 2; vectors; transformed cells; use in diagnosis of cancer |
| 02/20/2001 | US6191108 RH blood group antigen compositions and methods of use |
| 02/20/2001 | US6191104 Methods of treating graft rejection with the IL-17 receptor |
| 02/20/2001 | US6190909 TH2-specific gene |
| 02/20/2001 | US6190908 Modulation of polypeptide display on modified filamentous phage |
| 02/20/2001 | US6190897 Nucleotide sequence coding hydrolase; for use in digestion of animal feeds |
| 02/20/2001 | US6190884 Transforming host cell with polynucleotide which encodes the growth factor of defined amino acid sequence, and culturing for gene expression |
| 02/20/2001 | US6190881 Polynucleotide; recombinant production; drug screening of bactericides and enzyme inhibitors |
| 02/20/2001 | US6190876 KUZ, a novel family of metalloproteases |
| 02/20/2001 | US6190875 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 02/20/2001 | US6190874 Methods for identifying compounds that bind to CSAPK-1 |
| 02/20/2001 | US6190873 Mixing in aqueous medium the sample, a cyclosporin-label conjugate having specific linking groups, and antibodies capable of binding to cyclosporin-label conjugate; and determining presence of complex |
| 02/20/2001 | US6190871 Determining efficacy of monoclonal antibody to neutralize primary isolates by culturing various concentrations of antibody with virus and h9 cells, determining concentration of p24 antigen as indicator of infection, and comparing |
| 02/20/2001 | US6190863 Immunoglobulin m which recognizes gangioside gm2 which appears on human immunodeficiency virus infected t-cells; viricides; causes complement-mediated cytolysis in humans |